SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000318154-21-000042
Filing Date
2021-11-02
Accepted
2021-11-02 16:27:40
Documents
15
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amgn-20211102.htm   iXBRL 8-K 59476
2 EX-99.1 amgn-2021930xq3ex991.htm EX-99.1 562836
7 GRAPHIC amgenlogoa14a.jpg GRAPHIC 6206
  Complete submission text file 0000318154-21-000042.txt   876318

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20211102.xsd EX-101.SCH 3309
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20211102_def.xml EX-101.DEF 17806
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20211102_lab.xml EX-101.LAB 34940
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20211102_pre.xml EX-101.PRE 18154
8 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20211102_htm.xml XML 16860
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 211371732
SIC: 2836 Biological Products, (No Diagnostic Substances)